| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ADC.81.2.129 |
| P8608 | Fatcat ID | release_75e3d3ngxzdtreb24oimjeuldy |
| P932 | PMC publication ID | 1718033 |
| P698 | PubMed publication ID | 10490519 |
| P5875 | ResearchGate publication ID | 12808742 |
| P50 | author | Simon C Ling | Q38642068 |
| P2093 | author name string | J D Wilkinson | |
| J McColl | |||
| J Y Paton | |||
| A S Hollman | |||
| T J Evans | |||
| P2860 | cites work | Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London | Q24541328 |
| Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. | Q33623427 | ||
| Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis | Q34392767 | ||
| Liver disease and common-bile-duct stenosis in cystic fibrosis | Q39533300 | ||
| The relationship between chest radiographic scores and respiratory function tests in children with cystic fibrosis | Q40468887 | ||
| Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis | Q43551362 | ||
| Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells | Q45866124 | ||
| Effect of a Medium Dose of Ursodeoxycholic Acid with or without Taurine Supplementation on the Nutritional Status of Patients with Cystic Fibrosis | Q60199019 | ||
| A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto | Q68095095 | ||
| Liver cirrhosis: changes of Doppler waveform of hepatic veins | Q68182543 | ||
| Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration | Q70264571 | ||
| The changing epidemiology of cystic fibrosis | Q70528025 | ||
| Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis | Q71173367 | ||
| Liver disease in cystic fibrosis | Q71695013 | ||
| An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis | Q71997598 | ||
| Analysis of risk factors for the development of liver disease associated with cystic fibrosis | Q72274632 | ||
| Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? | Q73517330 | ||
| Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group | Q77958537 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| liver disease | Q929737 | ||
| P304 | page(s) | 129-132 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | The evolution of liver disease in cystic fibrosis | |
| P478 | volume | 81 |
| Q44927735 | Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. |
| Q33431380 | Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis |
| Q37850707 | Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation |
| Q79325382 | Liver involvement in cystic fibrosis |
| Q44980713 | Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. |
| Q35099096 | Metabolic liver disease in the young adult |
| Q84800550 | Outcome in Cystic Fibrosis Liver Disease |
| Q34992341 | Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. |
| Q64077819 | The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study |
| Q36085123 | The gallbladder and biliary tract in cystic fibrosis |
| Q80386847 | The role of abdominal ultrasound in the diagnosis, staging and management of cystic fibrosis liver disease |
| Q51141266 | Transient elastography in patients with cystic fibrosis. |
| Q46121018 | Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease. |
| Q84341387 | [Vaccination of cystic fibrosis patients] |
Search more.